United States· US:33342-157_bab34b9b-3e23-475d-a538-c0e3fe08be49
celecoxib
A medicinal product containing celecoxib, registered in United States by Macleods Pharmaceuticals Limited.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CELECOXIB
- Manufacturer
- Macleods Pharmaceuticals Limited
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc1133342-157-11
- ndc1133342-157-12
- ndc1133342-157-15
- ndc113334215711100 CAPSULE in 1 BOTTLE (33342-157-11)
- ndc11333421571210 BLISTER PACK in 1 CARTON (33342-157-12) / 10 CAPSULE in 1 BLISTER PACK
- ndc113334215715500 CAPSULE in 1 BOTTLE (33342-157-15)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/027b8aa6-33d3-43f1-b333-c68de70fec15 GET /v1/drugs/027b8aa6-33d3-43f1-b333-c68de70fec15?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "200",
"substance": "CELECOXIB",
"productndc": "33342-157",
"dosage_form": "CAPSULE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA204590",
"marketing_category": "ANDA"
}See everything about celecoxib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.